Literature DB >> 22026006

Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib.

Nicole M Fett, Mary B Toporcer, Josep Dalmau, Michi M Shinohara, Dan T Vogl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22026006     DOI： 10.1002/ajh.22131

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

2.  Dermato-neuro syndrome in a case of scleromyxedema.

Authors:  Yusuf Savran; Sevgi Akarsu
Journal:  Eur J Rheumatol       Date:  2015-04-22

3.  Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.

Authors:  Julie Delyon; Maud Bézier; Michel Rybojad; Josette Brière; Pierre Validire; Martine Bagot; Anne Janin; Maxime Battistella
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

Review 4.  Cutaneous manifestations of monoclonal gammopathy.

Authors:  Jean-Sebastien Claveau; David A Wetter; Shaji Kumar
Journal:  Blood Cancer J       Date:  2022-04-11       Impact factor: 11.037

5.  Characterization of circulating myeloma tumor cells by next generation flowcytometry in scleromyxedema patient: a case report.

Authors:  Ruba Y Taha; Saba Hasan; Firyal Ibrahim; Yannick Chantran; Hesham El Sabah; Siveen Sivaraman; Issam Al Bozom; Ahmad Al Sabbagh; Laurent Garderet; Halima El Omri
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.